News & Updates

Cataract surgery delivers no long-term risk of age-related macular degeneration

20 Nov 2021

Cataract surgery is safe and does not confer an increased risk of developing late age-related macular degeneration over 10 years of follow-up, according to a study.

Cataract surgery delivers no long-term risk of age-related macular degeneration

20 Nov 2021

Retinopathy of prematurity outcomes better with anti-VEGF than primary laser treatment

17 Nov 2021

Children with retinopathy of prematurity (ROP) who receive antivascular endothelial growth factor (anti-VEGF) therapy fare better than their counterparts who undergo primary laser treatment, a study has found.

Retinopathy of prematurity outcomes better with anti-VEGF than primary laser treatment

17 Nov 2021

Nasal spray eases signs, symptoms of dry eye disease

15 Nov 2021 by

The varenicline-containing nasal spray OC-01 appears beneficial in the treatment of dry eye disease, producing improvements in natural tear film production and patient-reported symptoms with a tolerable safety profile, as shown in the phase III trial ONSET-2.

Nasal spray eases signs, symptoms of dry eye disease

15 Nov 2021

Childhood myopia boom during COVID-19 pandemic a potential public health crisis

15 Nov 2021 by

Unprecedented quarantine and social distancing measures implemented during the coronavirus disease 2019 (COVID-19) pandemic have resulted in a “myopia boom” in school-aged children in Hong Kong, according to results of a population-based study by the Chinese University of Hong Kong (CUHK).

Childhood myopia boom during COVID-19 pandemic a potential public health crisis

15 Nov 2021

Automatic retinal image analysis identifies diabetes early with high sensitivity

15 Nov 2021 by

Screening of undiagnosed diabetes can be performed effectively with an automatic retinal image analysis (ARIA) technology developed by researchers at the Chinese University of Hong Kong (CUHK), instead of a finger-prink test.

Automatic retinal image analysis identifies diabetes early with high sensitivity

15 Nov 2021

Original New Drug Application Approvals by US FDA (16-31 October 2021)

07 Nov 2021

New drug applications approved by US FDA as of 16-31 October 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 October 2021)

07 Nov 2021

Retinal fluid volume variations during anti-VEGF maintenance therapy tied to worse VA

06 Nov 2021

Among patients with neovascular age-related macular degeneration (nAMD), fluctuations in retinal fluid volume during the maintenance phase antivascular endothelial growth factor (anti-VEGF) therapy may lead to long-term deterioration in visual acuity (VA), a recent study has found.

Retinal fluid volume variations during anti-VEGF maintenance therapy tied to worse VA

06 Nov 2021

Excision of ocular surface neoplasia with 2-mm margins yields low recurrence rates

06 Nov 2021

Excision of ocular surface squamous neoplasia (OSSN) with a 2-mm margin does not lead to high rates of positive surgical margins, a recent study has found. For patients who do show positive margins, adjuvant topical therapy is enough to prevent recurrence.

Excision of ocular surface neoplasia with 2-mm margins yields low recurrence rates

06 Nov 2021

Do face masks prevent endophthalmitis infection during anti-VEGF injections?

02 Nov 2021

Use of face masks by both patient and physician during intravitreal antivascular endothelial growth factor (anti-VEGF) injections does not modify the risk of presumed acute-onset bacterial endophthalmitis, but a reduced rate of culture-positive endophthalmitis is noted, reveals a study.

Do face masks prevent endophthalmitis infection during anti-VEGF injections?

02 Nov 2021

Bevacizumab reduces need for vitrectomy in PDR patients with vitreous haemorrhage

02 Nov 2021

Intravitreal bevacizumab (IVB) injections induce short-lived visual benefit but ease the need for vitrectomy in proliferative diabetic retinopathy (PDR) patients with vitreous haemorrhage (VH) who had undergone prior complete panretinal photocoagulation (PRP), a recent study has found.

Bevacizumab reduces need for vitrectomy in PDR patients with vitreous haemorrhage

02 Nov 2021

News & Updates

Filter by Specialty:

Specialty:

Cataract surgery delivers no long-term risk of age-related macular degeneration

Cataract surgery delivers no long-term risk of age-related macular degeneration

Retinopathy of prematurity outcomes better with anti-VEGF than primary laser treatment

Retinopathy of prematurity outcomes better with anti-VEGF than primary laser treatment

Nasal spray eases signs, symptoms of dry eye disease

Nasal spray eases signs, symptoms of dry eye disease

Childhood myopia boom during COVID-19 pandemic a potential public health crisis

Childhood myopia boom during COVID-19 pandemic a potential public health crisis

Automatic retinal image analysis identifies diabetes early with high sensitivity

Automatic retinal image analysis identifies diabetes early with high sensitivity

Original New Drug Application Approvals by US FDA (16-31 October 2021)

Original New Drug Application Approvals by US FDA (16-31 October 2021)

Retinal fluid volume variations during anti-VEGF maintenance therapy tied to worse VA

Retinal fluid volume variations during anti-VEGF maintenance therapy tied to worse VA

Excision of ocular surface neoplasia with 2-mm margins yields low recurrence rates

Excision of ocular surface neoplasia with 2-mm margins yields low recurrence rates

Do face masks prevent endophthalmitis infection during anti-VEGF injections?

Do face masks prevent endophthalmitis infection during anti-VEGF injections?

Bevacizumab reduces need for vitrectomy in PDR patients with vitreous haemorrhage

Bevacizumab reduces need for vitrectomy in PDR patients with vitreous haemorrhage